Triple-Negative Breast Cancer EVs Modulate Growth and Migration of Normal Epithelial Lung Cells

Ilaria Leone,Jessie Santoro,Antonio Soricelli,Antonio Febbraro,Antonio Santoriello,Barbara Carrese
DOI: https://doi.org/10.3390/ijms25115864
IF: 5.6
2024-05-29
International Journal of Molecular Sciences
Abstract:Breast cancer is the most common cancer amongst women worldwide. Recently, owing to screening programs and new technologies, the survival rate has increased significantly. Breast cancer can potentially develop metastases, and, despite them, lung metastases generally occur within five years of breast cancer diagnosis. In this study, the objective was to analyze the effect of breast cancer-derived EVs on a lung epithelial cell line. BEAS-2B cells were treated with extracellular vesicles (EVs) derived from triple-negative breast cancer cells (TNBCs), e.g., MDA-MB-231 and HS578T, separated using differential ultracentrifugation. We observed an increased growth, migration, and invasiveness of normal epithelial lung cells over time in the presence of TNBC EVs compared to the control. Therefore, these data suggest that EVs released by tumor cells contain biological molecules capable of influencing the pro-tumorigenic activity of normal cells. Exploring the role of EVs in oncology research and their potential cargo may be novel biomarkers for early cancer detection and further diagnosis.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
This paper mainly explores how extracellular vesicles (EVs) released by triple-negative breast cancer (TNBC) cells affect the growth and migration of normal lung epithelial cells. The study found that compared to the control group, the proliferation, migration, and invasiveness of normal lung epithelial cells (BEAS-2B cells) were increased when exposed to EVs produced by TNBC cells such as MDA-MB-231 and HS578T. These results suggest that EVs released by tumor cells may contain biomolecules that promote the tumorigenic activity of normal cells, which could be novel biomarkers for early cancer detection and further diagnosis. In addition, the purity and characteristics of EVs were validated through nanoparticle tracking analysis and immunoblotting, and the promotion of cell migration ability by EVs was demonstrated through scratch healing and Transwell migration experiments. The paper points out that these findings are of significance for understanding the mechanisms of breast cancer lung metastasis and identifying new therapeutic targets.